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Summary
 Background The linear quadratic model has led to various methods for the calculation of iso-
effect relationships in radiotherapy. In this model, the tissue sensitive parameters 
a and b usually appear as a ratio, a/b. These parameters are used to describe the 
response of normal tissues to radiation insult. Different radiation induced bio-
logical end points in speciﬁ c tissues and organs are associated with the charac-
teristics of the a/b ratio. The linear quadratic model has been used clinically to 
address questions relating to changes in fractions in treatment schedules.
 Aim The process of treating cancer with ionizing radiation is complex and subject to 
dosimetric errors which may potentially result in early or late complications. Our 
objective was to correct such errors through the application of the incomplete 
repair linear quadratic model.
 Materials/Methods Repair mechanisms are affected if, owing to dosimetric error, excess dose is delivered 
in single or multiple fractions. Corrections for such errors were simulated, for dif-
ferent clinical situations, in order to avoid late ﬁ brosis in head and neck cancers.
 Results NSD, CRE, and TDF approach could not predict, onset of proliferation, overall 
treatment time, late and early complications, but linear quadratic model calcu-
lations predicts isoeffective schedules successfully with above parameters.
 Conclusions In head and neck cancers, a number of parameters inﬂ uence the results of treat-
ment. Isoeffect calculations show the risk factors responsible for ﬁ brosis and spi-
nal cord damage and therefore may be used to calculate dose reductions for all 
remaining fractions, rather than applying shielding.
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cancers
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BACKGROUND
The linear quadratic model has led to various 
methods for the calculation of isoeffect relation-
ships in radiotherapy. In this model, the tissue 
sensitive parameters a and b usually appear as a 
ratio, a/b. These parameters are used to describe 
the response of normal tissues to radiation in-
sult. Different radiation induced biological end 
points in speciﬁ c tissues and organs are associat-
ed with the characteristics of the a/b ratio. The 
linear quadratic model has been used clinically 
to address questions relating to changes in frac-
tions in treatment schedules. The linear quad-
ratic model can be used to calculate the biolog-
ically effective dose, which makes two schedules 
equivalent to a particular biological end point. 
When multiple fractions are given each day, the 
repair processes arising from one radiation dose 
may not be complete as the half time for repair is 
relatively long, in comparison to the time interval 
between fractions. Incomplete repair tends to re-
duce the isoeffective dose and corrections must 
be made for the consequent loss of tolerance. In 
this article, isoeffect calculations are made based 
on the BED concept.
AIM
The aim of this present study is to calculate 
Biological Effective Dose in order to predict late 
ﬁ brosis in head and neck cancers, taking into ac-
count re-population corrections for normal cell 
proliferation in different clinical situations.
INTRODUCTION
The linear quadratic model describes a wide 
range of fractionation schedules that are iso-ef-
fective [1]. To apply this method we must ﬁ rst 
have a particular desired end point. The validi-
ty of the linear quadratic approach to fractiona-
tion depends principally on its ability to predict 
isoeffective schedules successfully [2]. There is 
an implicit assumption, that the isoeffect, has a 
direct relationship with a certain level of cell sur-
vival. Generally, the fraction of surviving cells as-
sociated with an isoeffect is unknown and it is 
customary to work in terms tissue effect levels, 
which we denote as E.
Effect (E) = -logeS
= D(a +bd) (1)
Dividing both sides of this equation by a, we ob-
tain
E =D [1+ d] (2)a       a        b
= Extrapolated Response Dose (ERD)
where
S – surviving fraction,
a –  coefﬁ cient of linear term (which determines 
the initial slope of the survival curve(Gy–1),
b –  coefﬁ cient of quadratic term (which deter-
mines the shape of the shoulder of the sur-
vival curve (Gy–2),
D – total dose delivered (Gy).
In order to account for the loss of dose due to re-
population, Orton [3] introduced a correction to 
ERD, termed the BED equation as follows,
BED = D [1+d/(a/b)] – K(T–To) (3)
Where K is the dose required per day to counter-
act proliferation, T is the overall treatment time 
and To is the onset time for proliferation.
BED is a measure of the effect [4] of a course of 
fractionated or continuous irradiation and has 
units of dose, usually expressed in grays.
The TE formulation is conceptually similar and 
has also been used in published literature [5]. In 
this case, we divide E by b rather than a to get.
Total Effect = E/b=D(a/b+d) (4)
The units of Total Effect are gray2, making the 
results less convenient than BED.
But note the simple conversion of Total Effect 
which is the product of a/b and BED (5).
MATERIALS AND METHODS
When multiple fractions per day are used [6], the 
repair of damage caused by one radiation dose 
may not be complete before the next fraction is 
given, especially if the half time for repair T1/2 is 
long in relation to the time interval between frac-
tions [7]. Incomplete repair tends to reduce the 
isoeffective dose and corrections must be made 
for the consequent loss of tolerance. This can be 
executed by the use of an incomplete repair mod-
el [8,9]. The amount of un-repaired damage is 
expressed by the function Hm which is dependent 
upon the number of equally spaced fractions (m). 
To represent the time interval between fractions, 
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for the purpose of isoeffect calculations, an extra 
term is added to the basic BED formula [9].
For fractionated radiotherapy
BED = D [1+d/(a/b)+Hm.d/(a/b)] (6)
where
d – dose per fraction,
D – total dose.
For continuous low dose rate radiotherapy
As the dose rate is reduced below the range used 
in external beam radiotherapy, the duration of ir-
radiation becomes longer, and the induction of 
damage is counteracted by repair, leading to an in-
crease in the isoeffective dose [10]. The BED for-
mula for continuous irradiation incorporates the 
factor (g) to allow for incomplete repair [11].
BED = D [1+ D.g/(a/b)] (7)
where
D is the total dose = dose rate X time.
Change of fraction size during treatment
Consider the situation when fraction size is 
changed without changing the overall duration 
of treatment time [12]. The formula required to 
calculate the biological effective dose is:
BED = D [1+ d/(a/b)] – K(T–To) (8)
where
D = total dose in n fractions of size d.
Assuming the conditions for a change of fraction 
size in BED calculations:
a)  select a value for a/b for a speciﬁ c tissue val-
ue,
b) select the reference tolerance dose Dref,
c)  select a fraction size for the reference treat-
ment (dref),
d)  calculate for the reference treatment: BED 
ref = Dref [1+ dref/(a/b)],
e)  for the new fraction dose, d, calculate the 
total dose.
D = BEDref/[1+d/(a/b)] (9)
For the ﬁ rst part of the treatment, calculate the 
partial BED value (PE1) from d1 and D1. The par-
tial tolerance remaining for the second part of 
the treatment is:
PE2 = BEDref-PE1 (10)
For the new fractional dose, d2, the, remaining 
total dose is given by:
D2 = PE2/[1+ d2/(a/b)] (11)
The same procedure can be adopted for more 
than two fraction sizes during treatment [11].
BED values were evaluated using equation [5] 
for the following values of LQ model variables 
[3] (Table 1).
RESULTS
A number of clinical reports and clinical reviews 
have shown a signiﬁ cant relationship between 
overall treatment time and Hendry normal tissue 
complication rate [13]. In order to reduce late 
complications, when doses in radiotherapy are 
changed by mistake, it is generally considered as 
an over dosage. In such cases. corrections must 
be made to alter the dose without changing the 
over all treatment time. The following are some 
example calculations, which illustrate the appli-
cation of linear quadratic equations for Head 
and Neck Cancer.
Example calculations
Example 1
The planned treatment was for 70Gy in 35 frac-
tions but, owing to dosimetric error, the ﬁ rst 6 
fractions were given as 4Gy/fraction, rather than 
2Gy/fraction. The accumulated dose is thus 24Gy 
in 6 fraction (OTT – 47days).
Treatment will be continued using 2Gy/frac-
tion
Question:
How many fractions of 2Gy should be given in 
order to maintain an equal probability of late ﬁ -
brosis?
Variable Value
α/β  3–3.5Gy [17]
K  0.78Gy [21]
To  28 days [19]
Table 1. LQ variables.
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Assumptions;
a/b = 3.5Gy Orton [3].
Solution: 
1. BED = 70×(1+2/3.5) –0.76(47–28) = 95.56 Gy
2. PE1 = 24×(1+4/3.5) = 51.4Gy PE for ﬁ rst 6 fr
3. PE2 = BED-PE1 = 44.16 D2 at 2Gy/fr
4.  D2 = 44.16/1.57 = 28.12Gy for 2Gy/fr 28.12/2 
= 14 fractions
Example 2
Planned treatment was for 50Gy in 25 fractions 
but, owing to dosimetric error, 6 fractions were 
given at a dose rate of 3Gy/fr instead of 2Gy/fr
Question:
How many fractions of 2Gy should be given in 
order to maintain an equal probability of late ﬁ -
brosis?
1. BED = 50×(1+2/3.5) –0.76(33–28) = 74.77Gy
2. PE1 = 18×(1=3/3.5) = 33.43Gy
3. PE2 = BED-PE1 = 41.34Gy
4. PE2 = D×(1+2/3.5) = 41.34Gy
5. D2 = 41.34/1.57 =26.33Gy
For 2Gy/fr 26.33/2 = 13 fractions
Example 3
Cancer of the oral tongue, stage T2 (3.5cm). The 
planned treatment is in two parts: 
I. External beam 50Gy in 25 fr followed by
II.  Interstitial implant delivering 30Gy in 3 
days.
Question:
If the total treatment were to be given in 2Gy/fr 
what would be the total biologically equivalent 
dose for late ﬁ brosis?
Assumptions:
a/b=3.5Gy
T1/2 =1.0hr
g.factor (3day) =0.04
1.  PE1 =50×(1+2/3.5) – 0.76(37–28) = 71.73Gy 
External beam
2.  PE2 =30×(1+(30×0.04/3.5) = 40.28Gy 
Brachytherapy
3. BED = 71.73+40.28 = 112.01Gy
4. BED D×(1+ 2  )= 112.01Gy
                      3.5
5. D = 112.01/1.57 = 71Gy in 2 Gy/fr.
Note: Owing to the smaller volumes and different 
dose distributions for interstitial irradiation, the 
calculated BED may be too high for an external 
beam irradiation. It is therefore recommended 
to reduce the dose for all fractions.
Example 4
The planned treatment is 4 fractions of 5Gy 
(2fr/week). After the ﬁ rst fraction, by mistake, 
a further single dose of 12Gy was given.
Question:
How much dose has been given for the 3 remain-
ing fractions?
a =3Gyb
for late complications [14].
1. BED =20×(1+ 5 )= 53.3Gy
                          3
2. PE1 = BED =12×(1+12 )= 60Gy
                          3
3. PE2 BED =20×(1+ 5 )= 60–53.3=6.7Gy
                          3
4. PE2 =D2×(1+ D2 ×3)= 60–53.3=6.7Gy
                          3
 6.7 = D2+(D2)
2/9
 0.111(D2)
2+D2–6.7
According to the quadratic equation =
D=–b+Öb2–4ac
            2a
a=0.111; b=1; c=–6.7
D2=4Gy d2=3Gy
Spinal cord tolerance calculations: 
a =2Gy  b        – for spinal cord damage [15]
BEDreference = 50(1+ 2 )= 100
                                  2
BEDplanned = 20(1+ 5 )= 70
                                  2
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BEDplanned = 0.7
BEDreference
Spinal cord tolerance below 30%
100 = Dmax =1+
5 
                       2
= 100/3.5=28.52=28Gy
A maximum of 5Gy should be given in the re-
maining 3 fractions.
DISCUSSION
Deviations from the predictions of the incomplete 
repair LQ model have become apparent under 
more extreme conditions, such as reduced spinal 
cord tolerance in the CHART regime (3 fr/day 
continuous over 12 days). Most of the deviations 
that have so far been observed from the LQ mod-
el may have arisen from the incorrect choice of 
two basic parameters a/b and T1/2. The results of 
these calculations must only be taken as a guide to 
clinical practice. The linear quadratic approach 
to fractionation overcomes some of the deﬁ cien-
cies of the NSD and TDF concepts [16]. The va-
lidity of the equations is limited to more or less 
standard conditions. Deviations from the pre-
dictions of the incomplete-repair linear quad-
ratic model have become apparent under more 
extreme conditions. As experience grows, appli-
cations for this method of calculation will become 
more evident.
CONCLUSIONS
Using these calculations only as a guide, the lin-
ear quadratic approach to fractionation over-
comes some of the potential deﬁ ciencies of the 
TDF approach, but cannot be claimed to be uni-
versally correct. In reality it would be surprising 
if such simple equations satisfactorily described 
all the possible effects of changing dose pre-
scriptions in radiotherapy. Neither the TDF nor 
the LQ based approach may be put in to clini-
cal use directly without ﬁ rst cross checking ret-
rospective clinical data. The solutions obtained 
through these calculations should be considered 
as rough estimates only. When no clinical experi-
ence is available, upon which to base a decision, 
it may be necessary to resort to such a mathe-
matical model.
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